YIDU TECH (02158) Reinitiates Share Buyback to Signal Confidence, Announces New International Medical Collaboration Project at Winter Davos

Stock News

Jan 27

On January 27, YIDU TECH (02158) announced that it repurchased 378,600 shares on the same day at a price of approximately HK$6 per share, amounting to nearly HK$2.3 million. This marks the second consecutive day of buybacks, bringing the total repurchased shares to 505,000 with a cumulative buyback value exceeding HK$3 million. In related news, Gong Rujing, the Founder and Chairperson of YIDU TECH, was recently invited to attend the 2026 Winter Davos Forum, participating in multiple high-level industry dialogues and closed-door meetings while holding intensive discussions with global leaders and partners from government, business, and academia. At the forum, Dr. Giovanni Caforio, Chairman of the Board of Novartis, announced a significant collaboration: the Novartis Foundation, the Ministry of Health of Brunei, and EVYD, a subsidiary of YIDU TECH, will jointly implement a data- and AI-driven cardiovascular disease prevention and control project—CARDIO4Cities. Concurrently, the release of an authoritative industry ranking further validates YIDU TECH's leading position in the sector. The "2025 Healthcare Big Data Enterprise Ranking" was officially unveiled, and YIDU TECH, leveraging its profound technological expertise, mature product portfolio, and extensive industry implementation experience, secured the top spot for the seventh consecutive year, continuing to lead the healthcare big data field.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1126285466"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1126285466\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1126285466?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-27 19:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126285466","market":"fut","top_or_hot":-1,"title":"YIDU TECH (02158) Reinitiates Share Buyback to Signal Confidence, Announces New International Medical Collaboration Project at Winter Davos","media":"Stock News","content":"<p>On January 27, YIDU TECH (02158) announced that it repurchased 378,600 shares on the same day at a price of approximately HK$6 per share, amounting to nearly HK$2.3 million. This marks the second consecutive day of buybacks, bringing the total repurchased shares to 505,000 with a cumulative buyback value exceeding HK$3 million. In related news, Gong Rujing, the Founder and Chairperson of YIDU TECH, was recently invited to attend the 2026 Winter Davos Forum, participating in multiple high-level industry dialogues and closed-door meetings while holding intensive discussions with global leaders and partners from government, business, and academia. At the forum, Dr. Giovanni Caforio, Chairman of the Board of Novartis, announced a significant collaboration: the Novartis Foundation, the Ministry of Health of Brunei, and EVYD, a subsidiary of YIDU TECH, will jointly implement a data- and AI-driven cardiovascular disease prevention and control project—CARDIO4Cities. Concurrently, the release of an authoritative industry ranking further validates YIDU TECH's leading position in the sector. The \"2025 Healthcare Big Data Enterprise Ranking\" was officially unveiled, and YIDU TECH, leveraging its profound technological expertise, mature product portfolio, and extensive industry implementation experience, secured the top spot for the seventh consecutive year, continuing to lead the healthcare big data field.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>YIDU TECH (02158) Reinitiates Share Buyback to Signal Confidence, Announces New International Medical Collaboration Project at Winter Davos</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYIDU TECH (02158) Reinitiates Share Buyback to Signal Confidence, Announces New International Medical Collaboration Project at Winter Davos\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-27 19:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On January 27, YIDU TECH (02158) announced that it repurchased 378,600 shares on the same day at a price of approximately HK$6 per share, amounting to nearly HK$2.3 million. This marks the second consecutive day of buybacks, bringing the total repurchased shares to 505,000 with a cumulative buyback value exceeding HK$3 million. In related news, Gong Rujing, the Founder and Chairperson of YIDU TECH, was recently invited to attend the 2026 Winter Davos Forum, participating in multiple high-level industry dialogues and closed-door meetings while holding intensive discussions with global leaders and partners from government, business, and academia. At the forum, Dr. Giovanni Caforio, Chairman of the Board of Novartis, announced a significant collaboration: the Novartis Foundation, the Ministry of Health of Brunei, and EVYD, a subsidiary of YIDU TECH, will jointly implement a data- and AI-driven cardiovascular disease prevention and control project—CARDIO4Cities. Concurrently, the release of an authoritative industry ranking further validates YIDU TECH's leading position in the sector. The \"2025 Healthcare Big Data Enterprise Ranking\" was officially unveiled, and YIDU TECH, leveraging its profound technological expertise, mature product portfolio, and extensive industry implementation experience, secured the top spot for the seventh consecutive year, continuing to lead the healthcare big data field.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02158","symbol_name":"医渡科技","start_time":0,"source_url":"","article_id":"1126285466","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126285466","pubTimestamp":1769515124,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"On January 27, YIDU TECH (02158) announced that it repurchased 378,600 shares on the same day at a price of approximately HK$6 per share, amounting to nearly HK$2.3 million. This marks the second...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159891":"医疗","02158":"医渡科技","BK1518":"SaaS概念","BK1189":"医疗保健技术","BK1617":"AI医疗"},"translate_title":"医渡科技(02158)重启股份回购释放信心冬季达沃斯宣布新国际医疗合作项目","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159891":1,"02158":1},"content_text":"On January 27, YIDU TECH (02158) announced that it repurchased 378,600 shares on the same day at a price of approximately HK$6 per share, amounting to nearly HK$2.3 million. This marks the second consecutive day of buybacks, bringing the total repurchased shares to 505,000 with a cumulative buyback value exceeding HK$3 million. In related news, Gong Rujing, the Founder and Chairperson of YIDU TECH, was recently invited to attend the 2026 Winter Davos Forum, participating in multiple high-level industry dialogues and closed-door meetings while holding intensive discussions with global leaders and partners from government, business, and academia. At the forum, Dr. Giovanni Caforio, Chairman of the Board of Novartis, announced a significant collaboration: the Novartis Foundation, the Ministry of Health of Brunei, and EVYD, a subsidiary of YIDU TECH, will jointly implement a data- and AI-driven cardiovascular disease prevention and control project—CARDIO4Cities. Concurrently, the release of an authoritative industry ranking further validates YIDU TECH's leading position in the sector. The \"2025 Healthcare Big Data Enterprise Ranking\" was officially unveiled, and YIDU TECH, leveraging its profound technological expertise, mature product portfolio, and extensive industry implementation experience, secured the top spot for the seventh consecutive year, continuing to lead the healthcare big data field.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}